Haemonetics (HAE) PT Raised to $40 at Jefferies

Go back to Haemonetics (HAE) PT Raised to $40 at Jefferies

Haemonetics (HAE) Misses Q1 EPS by 3c

August 1, 2016 8:30 AM UTC

Haemonetics (NYSE: HAE) reported Q1 EPS of $0.25, $0.03 worse than the analyst estimate of $0.28. Revenue for the quarter came in at $210 million versus the consensus estimate of $205.41 million.

For earnings history and earnings-related data on Haemonetics (HAE) click here.

... More

Haemonetics (HAE) Names New CFO

August 1, 2016 6:10 AM UTC

Haemonetics Corporation (NYSE: HAE) announced that William P. Burke will join the Company as Chief Financial Officer, effective August 8, 2016. In this role, he will oversee the Company's treasury, controllership and accounting, investor relations, tax and financial planning and analysis functions.

Mr. Burke will... More